Recombinant bovine somatotropin (rbST) has renewed movement forward for Codex approval.

This week, the Codex Alimentarius Commission, a body of the World Health Organization and Food and Agriculture Organization of the United Nations, held rbST at Step 8, providing the opportunity for an updated review of the scientific data.

This decision is in recognition of the established human safety decisions from years past ― and the opportunity for additional scientific review.

“While we wish the standards had been adopted, we also look forward to updating the established human safety data assessment,” says Ted McKinney, director of global public affairs at Elanco. “To achieve approval at some point in the future would be similar to receiving product approval from a regulatory body here in the U.S.”

The Codex endorsement provides reassurance to countries throughout the world that a product is efficacious and safe.

Years ago, rbST was submitted for review, but it sat dormant at the final Step 8 until one country asked to advance the process. 

“Elanco respects the decision taken by Codex regarding the global food safety standards for recombinant bovine somatotropin (rbST). We compliment the large number of countries at Codex that expressed support at this session for the adoption of food standards for rbST. Global dairy innovations, such as rbST, are and will continue to be instrumental in meeting the rising demand for safe, wholesome dairy products. Codex standards provide an international food safety reference point that helps assure consumers that their food is safe,” says Jeff Simmons, president of Elanco.